CARPE DIEM
VISION
MISSION
• Re-establish Centinel Spine’s leadership
in the Stand-Alone space.
• Further expand our breadth and depth
of product offering for the cervical spine.
• Further expand the Centinel Spine brand.
• Become the “Go-To” product in cervical.
Create a new market segment and take
further market share of the current $500MM
ACDF market. Through the successful roll
out of our STALIF C-Ti™, we will expand our
current business, re-capture lost business,
and grow our user base.
Goals
Competitive Advantage
• Double our STALIF C user base by the end
of 2015.
• Establish Centinel Spine as an innovator
• Use STALIF C-Ti™ as a leading selling tool to
get in new users’ doors.
• Re-engage our distributor network
• Provide superior outcomes for the patient.
• Redefine Centinel Spine as the leader in the
Stand-Alone and Integrated Interbody™ spaces.
• Set the stage for the series of future new
product launches.
• STALIF C-Ti™ will provide all the advantages
of PEEK with regards to having the same
modulus of elasticity as bone, and ability to
radiographically image, along with all of the
osteo-integrating capabilities of titanium.
• We will be first to market with a Ti-coated
product for cervical vs. our main competition
of J&J, Globus, and LDR.
• We will give our distribution network what
will be viewed as a truly differentiated
product to sell.
Product Concept
Business Opportunity
We develop, sell, and manufacture Integrated
Interbody™ devices that are also Stand-Alone
and No-Profile®. We are bringing to market
the STALIF C-Ti™ which augments the benefits
of our current product with enhanced biologic
performance afforded by a titanium coating.
• Expand our product offering to Ti-coated
devices.
• Lead in creating a new category of implants
that will change the market. Enhance patient
care and provide improved outcomes.
• Give Centinel Spine first mover advantage. • Expand our user base.
CONFIDENTIAL